Overview

Observational Retrospective Study of Effectivity and Tolerability in Patients With Lacosamide Medication

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Lacosamide is an antiepileptic drug approved for using like adjuvant treatment in adults epileptic crisis. Previous studies has granted to the adjuvant therapy a significant efficacy. This is an observational study, multicenter and retrospective, in patients with epilepsy. The aim of study is the evaluation of the adjuvant treatment with Lacosamide administered over 12 months. The investigators will collect information from 860 patients in 13 spanish centers. The secondary aim is assess the tolerability of treatment during 3,6 and 12 month.
Details
Lead Sponsor:
Instituto de Investigacion Sanitaria La Fe
Treatments:
Lacosamide